BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34719299)

  • 1. Patient-reported outcome measures in systemic lupus erythematosus by a web-based application: A randomized, crossover, agreement study.
    Uhrenholt L; Høstgaard S; Pedersen JF; Christensen R; Dreyer L; Leffers HCB; Taylor PC; Strand V; Jacobsen S; Voss A; Gregersen JW; Kristensen S
    Lupus; 2021 Nov; 30(13):2124-2134. PubMed ID: 34719299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quick Systemic Lupus Activity Questionnaire (Q-SLAQ): a simplified version of SLAQ for patient-reported disease activity.
    Svenungsson E; Gunnarsson I; Illescas-Bäckelin V; Trysberg E; Jönsen A; Leonard D; Sjöwall C; Pettersson S
    Lupus Sci Med; 2021 May; 8(1):. PubMed ID: 33972457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translation, cultural adaptation and validation of the Systemic Lupus Erythematosus Activity Questionnaire (SLAQ) in a cohort of Italian systemic lupus erythematosus patients.
    Tani C; Vagelli R; Stagnaro C; Carli L; Lorenzoni V; Drago F; Doherty W; McSorley MR; Marconcini L; Della Rossa A; Turchetti G; Mosca M
    Lupus; 2018 Sep; 27(10):1735-1741. PubMed ID: 30045666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using a novel smartphone application for capturing of patient-reported outcome measures among patients with inflammatory arthritis:A randomized, crossover, agreement study.
    Uhrenholt L; Christensen R; Dreyer L; Schlemmer A; Hauge EM; Krogh NS; Abildtoft MK; Taylor PC; Kristensen S
    Scand J Rheumatol; 2022 Jan; 51(1):25-33. PubMed ID: 34151710
    [No Abstract]   [Full Text] [Related]  

  • 5. Quantitative data for care of patients with systemic lupus erythematosus in usual clinical settings: a patient Multidimensional Health Assessment Questionnaire and physician estimate of noninflammatory symptoms.
    Askanase AD; Castrejón I; Pincus T
    J Rheumatol; 2011 Jul; 38(7):1309-16. PubMed ID: 21459938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing longitudinal patient-reported outcome measures between Swedish patients with recent-onset systemic lupus erythematosus and early rheumatoid arthritis.
    Heijke R; Björk M; Thyberg I; Kastbom A; McDonald L; Sjöwall C
    Clin Rheumatol; 2022 May; 41(5):1561-1568. PubMed ID: 34839415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of patients' and physicians' assessments of disease activity using the Swedish version of the Systemic Lupus Activity Questionnaire.
    Pettersson S; Svenungsson E; Gustafsson J; Möller S; Gunnarsson I; Welin Henriksson E
    Scand J Rheumatol; 2017 Nov; 46(6):474-483. PubMed ID: 28293972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using Clinical Characteristics and Patient-Reported Outcome Measures to Categorize Systemic Lupus Erythematosus Subtypes.
    Rogers JL; Eudy AM; Pisetsky D; Criscione-Schreiber LG; Sun K; Doss J; Clowse MEB
    Arthritis Care Res (Hoboken); 2021 Mar; 73(3):386-393. PubMed ID: 31909888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation and adaptation of the Spanish version of the systemic lupus activity questionnaire (S-SLAQ) in an Argentinean population.
    Catoggio C; Martínez Muñoz A; Chaparro Del Moral R; Klajn DS; Papasidero SB; Machado Escobar MA; Gonzalez Lucero L; Lucero E; Martinez L; Muñoz SA; Collado MV; Gomez GN; Sarano J; Marin J; Scolnik M; Romero J; Barreira JC; Zalazar MM; Rillo OL; Pisoni C
    Lupus; 2021 Dec; 30(14):2230-2236. PubMed ID: 34894851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of fatigue on health-related quality of life and illness perception in a monocentric cohort of patients with systemic lupus erythematosus.
    Elefante E; Tani C; Stagnaro C; Ferro F; Parma A; Carli L; Signorini V; Zucchi D; Peta U; Santoni A; Raffaelli L; Mosca M
    RMD Open; 2020 Feb; 6(1):. PubMed ID: 32075876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indices to assess patients with systemic lupus erythematosus in clinical trials, long-term observational studies, and clinical care.
    Castrejón I; Tani C; Jolly M; Huang A; Mosca M
    Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-85-95. PubMed ID: 25365095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibromyalgia, systemic lupus erythematosus (SLE), and evaluation of SLE activity.
    Wolfe F; Petri M; Alarcón GS; Goldman J; Chakravarty EF; Katz RS; Karlson EW
    J Rheumatol; 2009 Jan; 36(1):82-8. PubMed ID: 19004039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The minimally important difference for patient reported outcomes in systemic lupus erythematosus including the HAQ-DI, pain, fatigue, and SF-36.
    Colangelo KJ; Pope JE; Peschken C
    J Rheumatol; 2009 Oct; 36(10):2231-7. PubMed ID: 19723907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the Japanese version of the Systemic Lupus Activity Questionnaire that includes physician-based assessments in a large observational cohort.
    Okamoto Y; Katsumata Y; Baba S; Kawaguchi Y; Gono T; Hanaoka M; Kawasumi H; Yamanaka H
    Lupus; 2016 Apr; 25(5):486-95. PubMed ID: 26589578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of patient-reported outcome measures to classify type 1 and 2 systemic lupus erythematosus activity.
    Eudy AM; Reeve BB; Coles T; Lin L; Rogers JL; Pisetsky DS; Criscione-Schreiber LG; Doss J; Sadun R; Sun K; Clowse ME
    Lupus; 2022 May; 31(6):697-705. PubMed ID: 35343853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the systemic lupus erythematosus activity questionnaire in a large observational cohort.
    Yazdany J; Yelin EH; Panopalis P; Trupin L; Julian L; Katz PP
    Arthritis Rheum; 2008 Jan; 59(1):136-43. PubMed ID: 18163398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation and evaluation of the German version of the Systemic Lupus Activity Questionnaire (SLAQ).
    Chehab G; Richter J; Sander O; Fischer-Betz R; Ostendorf B; Al-Neyadi T; Vordenbäumen S; Acar H; Brinks R; Schneider M
    Clin Exp Rheumatol; 2015; 33(3):354-9. PubMed ID: 25797042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a Systemic Lupus Activity Questionnaire (SLAQ) for population studies.
    Karlson EW; Daltroy LH; Rivest C; Ramsey-Goldman R; Wright EA; Partridge AJ; Liang MH; Fortin PR
    Lupus; 2003; 12(4):280-6. PubMed ID: 12729051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of care in systemic lupus erythematosus: the association between process and outcome measures in the Lupus Outcomes Study.
    Yazdany J; Trupin L; Schmajuk G; Katz PP; Yelin EH
    BMJ Qual Saf; 2014 Aug; 23(8):659-66. PubMed ID: 24614054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward electronic health recording: evaluation of electronic patient reported outcome measures (e-PROMs) system for remote monitoring of early systemic lupus patients.
    El Miedany Y; El Gaafary M; El Aroussy N; Bahlas S; Hegazi M; Palmer D; Youssef S
    Clin Rheumatol; 2017 Nov; 36(11):2461-2469. PubMed ID: 28567555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.